Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery

M. Sharma; R. Nayar; Y. Graham; H.M. Parretti; S. Abbott; A. Tahrani; A.D. Miras; B. Madhok; R. Singhal; K. Mahawar

doi:10.1007/s11695-022-06044-6

Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery

M. Sharma
, R. Nayar
, Y. Graham
, H.M. Parretti
, S. Abbott
, A. Tahrani
, A.D. Miras
, B. Madhok
, R. Singhal
, K. Mahawar

Sunderland Royal Hospital

Research output: Contribution to journal › Letter › peer-review

5 Citations (Scopus)

Original language	English
Journal	Obesity Surgery
Early online date	28 Apr 2022
DOIs	https://doi.org/10.1007/s11695-022-06044-6
Publication status	Published (in print/issue) - 31 Jul 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s11695-022-06044-6

Cite this

@article{a87c14fd1ca4452b8638937c393f949f,

title = "Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery",

author = "M. Sharma and R. Nayar and Y. Graham and H.M. Parretti and S. Abbott and A. Tahrani and A.D. Miras and B. Madhok and R. Singhal and K. Mahawar",

year = "2022",

month = jul,

day = "31",

doi = "10.1007/s11695-022-06044-6",

language = "English",

journal = "Obesity Surgery",

issn = "0960-8923",

publisher = "Springer",

}

TY - JOUR

T1 - Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery

AU - Sharma, M.

AU - Nayar, R.

AU - Graham, Y.

AU - Parretti, H.M.

AU - Abbott, S.

AU - Tahrani, A.

AU - Miras, A.D.

AU - Madhok, B.

AU - Singhal, R.

AU - Mahawar, K.

PY - 2022/7/31

Y1 - 2022/7/31

UR - https://www.scopus.com/pages/publications/85129085829

U2 - 10.1007/s11695-022-06044-6

DO - 10.1007/s11695-022-06044-6

M3 - Letter

C2 - 35482224

SN - 0960-8923

JO - Obesity Surgery

JF - Obesity Surgery

ER -

Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery

UN SDGs

Access to Document

Other files and links

Cite this